Outcomes, challenges and prospects of emicizumab prophylaxis in Sub-Saharan Africa – Insights from the Tanzanian experience
Prophylaxis is the global standard of care for haemophilia A (HA), and its adoption has been accelerated by wide use of emicizumab prophylaxis globally. Reports on the prophylaxis in people with haemophilia living in Africa are limited.
Saved in:
| Main Authors: | Mwakichako Rebbecca Wughanga, Mnkugwe Rajabu Hussein, Chamba Clara, Kunambi Peter, Bruckman Martha, Schuh Anna, Munroe Michelle, Kaaya Gladys, Ally Mwashungi, Nasser Ahlam, Mawala William, Lyimo Magdalena, Mahlangu Johnny, Rwezaula Stella |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2025-03-01
|
| Series: | The Journal of Haemophilia Practice |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/jhp-2025-0005 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Severe haemophilia A with haemarthrosis improved on emicizumab: A case report
by: Wasifuddin Mustafa, et al.
Published: (2025-03-01) -
Real‐world use of emicizumab in Chinese children with hemophilia A: Retrospective data from a comprehensive care center
by: Qianqian Mao, et al.
Published: (2024-12-01) -
Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis: from evidence to clinical practice
by: Robert F. Sidonio, Jr., et al.
Published: (2025-05-01) -
TSUBASA study: evaluation of the quality and content of daily life of people with hemophilia A without factor VIII inhibitors on prophylactic treatment with emicizumab
by: Teruhisa Fujii, et al.
Published: (2025-07-01) -
Mental Health, Work Productivity, and Quality of Life in People with Severe Haemophilia A Receiving Prophylaxis: Findings from the CHESS Data Platform
by: Pratima Chowdary, et al.
Published: (2025-01-01)